Colorado Cancer Action Center

The American Cancer Society Cancer Action Network (ACS CAN) applauds the Colorado General Assembly for taking a great first step to increasing access to biomarker testing by passing SB24-124. The bill was met with strong bi-partisan support in both the House and Senate. With the legislative process now complete, the bill now awaits the signature of Governor Jared Polis. If enacted, the policy would help connect more patients diagnosed with cancer or other diseases with the right treatment at the right time through biomarker testing.

DENVER, COLO. — MARCH 13, 2024 — American Cancer Society Cancer Action Network (ACS CAN) volunteers from across Colorado convened at the State Capitol on Wednesday. They urged lawmakers to pass SB 124, which if enacted would ensure  biomarker testing is covered by more insurance plans, including Health First Colorado, when supported by medical and scientific evidence.

The American Cancer Society Cancer Action Network (ACS CAN) hosted its 15th annual Colorado Policy Forum at the University of Colorado Cancer Center, Wednesday evening. Leaders from the public health, business, education, and government sectors gathered learn about the work being done to try to end cancer in the state.

Attorneys General for six states and DC today announced a $462 million multi-state settlement to be paid out by JUUL Labs, following an investigation into its underage marketing practices to attract youth to its addictive e-cigarettes.